INS and chronic kidney disease: The subgroups differed in terms of escalation of therapy and complications; for example, individuals in the severe autoimmune and severe insulin deficient clusters had the shortest times to sustained insulin use, and those in the severe insulin resistance cluster had the highest risk of developing chronic kidney disease.